top of page
FDA Approved: New Long-Acting PrEP Regimen and Its Implications
In June 2025, the US Food and Drug Administration approved a new HIV pre-exposure prophylaxis (PrEP) regimen: the long-acting injectable...
Jun 2330 min read
The Construction of Innovation Ecosystems as a National Strategy: The Case of Health
In the contemporary global landscape, the concept of an isolated national economy has become a fiction. Nations do not compete solely for...
Feb 206 min read
The Importance of Regulatory Agencies in Health Innovation and Pharmaceutical Regulation: FDA, EMA, and ANVISA in Perspective
Health innovation and the remarkable growth of the pharmaceutical sector—with a projected global revenue of USD 1.155 trillion in...
Nov 1, 20244 min read
bottom of page